Huus, K.: Evolutionary histories and adaptations of human gut microbiota. 3rd International Conference Controlling Microbes to Fight Infections (CMFI 2023), Tübingen, Germany (2023)

Ley, R.: Evolutionary histories and adaptations of human gut microbiota. 3rd International Conference Controlling Microbes to Fight Infections (CMFI 2023), Tübingen, Germany (2023)

Maier, L.: The consequences of drugging the gut microbiome: from the individual microbe to the host. 3rd International Conference Controlling Microbes to Fight Infections (CMFI 2023), Tübingen, Germany (2023)

Ley, R.: Silent flagellins, or how the gut immune system turns a blind eye. EMBO EMBL Symposium: The Human Microbiome , Heidelberg, Germany (2023)

Ley, R.: Humans and their gut microbes: shared evolutionary trajectories and adaptations. Cell Symposia: Infection Biology in the Age of the Microbiome, Paris, France (2023)

Ley, R.: Microbiomes & Microbial Interactions. EMBO EMBL Symposium: New approaches and concepts in microbiology , Heidelberg, Germany (2023)

Ley, R.: Codiversification of humans with gut and oral microbiota and their characteristics. EMBO EMBL Symposium: New approaches and concepts in microbiology , Heidelberg, Germany (2023)

Ley, R.: Humans and their gut microbes: shared evolutionary trajectories and adaptations. Max-Planck-Campus Tübingen: Distinguished Speaker Seminar Series (DSSS), Tübingen, Germany (2023)

Huus, K.: From famine to fever: immunity, diet, and the microbiome. University of Ottawa: Special Seminar Series on Microbiomes, Ottawa, Canada (2022)

Ley, R.: Silent Recognition of Flagellins from Human Gut Commensal Bacteria by Toll-Like Receptor 5. Keystone Symposia: Novel Approaches Against Emerging Antimicrobial Resistance (RQ4), Banff, AB, Canada (2022)

Suzuki, T.: Codiversification of gut microbiota with humans. Keystone Symposia: Novel Approaches Against Emerging Antimicrobial Resistance (RQ4), Banff, AB, Canada (2022)

Marsh, J.: Toward Microbiome Engineering: Expanding the Repertoire of Genetically Tractable Members of the Human Gut Microbiome. New Horizons in Precision Medical Imaging and Therapy Symposium, Tübingen, Germany (2022)

Ley, R.: Silent recognition of flagellin from human gut commensal bacteria by toll-like receptor 5. EMBO EMBL Symposium: Innate immunity in host-pathogen interactions, Heidelberg, Germany (2022)

Ley, R.: The human gut microbiome: ecology and evolution. Bayer Foundation: Boundary Breaking Science Lecture Series (2022)

Suzuki, T.: Codiversification of gut microbiota with humans and the role of microbes in mammalian ecology and evolution. The Center for Ecological Research: CER Seminars, Kyoto, Japan (2021)

Ley, R.: The Interplay Between Host Genetics and the Human Gut Microbiota. San Diego Digestive Diseases Research Center (SDDRC), San Diego, CA, USA (2020)

Ley, R.: Microbiota and metabolic diseases. EMBO FEBS Lecture Course: The new microbiology, Spetses Island, Greece (2019)

Ley, R.: Coevolution of humans with their microbiomes. EMBO FEBS Lecture Course: The new microbiology, Spetses Island, Greece (2019)

Huus, K.: The Development of IgA-Lactobacillus Interactions Is Disrupted during Malnutrition and Environmental Enteropathy. Keystone Symposium: Microbiome, Host Resistance and Disease (X4), Banff, AB, Canada (2018)

Ley, R.: Sphingolipid Production by Gut Microbes Impacts Host Metabolism. Keystone Symposium: Microbiome, Host Resistance and Disease (X4), Banff, AB, Canada (2018)